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Abstract: Stress is the major predisposing and precipitating factor in the onset of depression which is the most significant 
mental health risk for women. Behavioral studies in animal models show that female sex though less affected by an acute 
stressor; exposure to repeated stressors induces coping deficits to impair adaptation in them. A decrease in the function  
of 5-hydroxytryptamine (5-HT; serotonin) in the hippocampus and an increased function of the 5-HT-1A receptor in the 
raphe nucleus coexist in depression. Pharmacological and neurochemical data are relevant that facilitation of serotonin 
neurotransmission via hippocampus due to desensitization of somatodendritic 5-HT1A receptors may lead to adaptation to 
stress. The present article reviews research on sex related differences of raphe-hippocampal serotonin neurotransmission 
to find a possible answer that may account for the sex differences of adaptation to stress reported in preclinical research 
and greater incidence of depression in women than men.  
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1. INTRODUCTION 
  It is well accepted that males and females can behave 
differently but how much of that difference is attributable to 
genetic, environmental and neurobiological factors has often 
been a matter of debate [1-3]. Evidence suggests that the 
effects of sex hormones on brain organization occur so early 
in life that from the start the environment is acting on differ-
ently wired brains in the two sexes. Human studies on sex 
differences of brain function are often supported by preclini-
cal research suggesting that the differences are attributable to 
biological differences between males and females because 
there are few environmental or socio-cultural factors to con-
sider in preclinical research.  
  Women are at least twice as likely as men to suffer from 
depression and anxiety [4-6]. These sex differences are seen 
in different countries and cultures, suggesting a biological 
basis. Evidence from animal studies also suggests that be-
havioral and neurobiological effects of stress are sexually 
dimorphic. However, despite great interest in this area [7], 
mechanisms that may contribute to this striking sex differ-
ence have remained elusive. 
  A dysfunctional 5-hydroxytryptamine (5-HT; serotonin)-
ergic system is a vulnerability factor for major depressive 
disorder and other forms of affective illnesses [2]. At least 14 
different types and subtypes of serotonin receptors have been 
identified [8]. A number of these receptors such as 5-HT-2 
[9, 10], 5-HT-3 [11] and 5-HT-1A [12] receptors play a role 
in the genesis of psychiatric illnesses. Studies on animal 
models show that raphe hippocampal serotonin neurotrans-
mission and its regulation via 5-HT-1A receptors can explain 
vulnerability or resistance to stress stimuli. The 5-HT-1A 
receptor which is a key mediator of serotonergic signaling in  
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the central nervous system is also implicated in the mecha-
nism of action of selective serotonin reuptake inhibitors 
(SSRIs) [13-16], while some studies indicate that sex may 
moderate the response to antidepressants with women exhib-
iting a preferential response to SSRIs compared to tricyclic 
antidepressants (TCAs) [17]. 
  Cell bodies of serotonin containing neurons are located in 
the raphe nuclei in the brain stem. The 5-HT-1A receptor is a 
G-protein-coupled receptor widely distributed in regions that 
receive serotonergic input from the raphe nuclei: the frontal 
cortex, septum, amygdale, hippocampus and hypothalamus 
[18, 19]. It also serves as somatodendritic autoreceptor of 
raphe nuclei reducing the firing rate of serotonergic neurons 
[8, 20-22]. The hippocampus has been extensively studied 
with regard to stress, depression and antidepressant action 
[23-25]. Sex related differences of raphe-hippocampal sero-
tonin neurotransmission with a particular focus on 5-HT-1A 
receptors are accumulated in the present review as this may 
account for the gender differences of adaptation to stress and 
greater incidence of depression in women than men. 
2. STRESS, DEPRESSION AND THE GENDER   
DIFFERENCE 
  The hypothesis that stress is the major precipitating fac-
tor in the onset of depression is consistently supported by 
clinical and preclinical studies [26-28] showing the relation-
ship between previous traumatic stressful event (predispos-
ing factor) and subsequent other stressor (precipitating fac-
tor). Both physical and psychological stressors have been 
shown to lead to the onset of a depressive episode. Sex in 
genetically predisoposed subjects may result in depression 
[29]. Studies in female twins show a clear interaction be-
tween genetic loading and exposure to a recent stressful life 
event in the precipitation of depressive episode [30].  
  In a study of 4,856 individuals (53% female) experienc-
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adverse life events are associated with different depressive 
symptoms profile [31]. In a follow-up study of over 7 years 
in 266 middle aged women, without a history of major de-
pression at base line, 15.8% women met criteria for major 
depression [32]. These researchers reported that lifetime his-
tory of anxiety disorder and very stressful life events are 
important contributing factors in the onset of first episode of 
major depression. 
  Major depressive disorder is two times more prevalent in 
women than in men [4, 6, 33, 34]. The mean age of onset, 
the overall course of depression and the risk for chronic or 
recurrent depression does not differ between sexes [35], al-
though some studies suggest that women have a higher rate 
of recurrent depression and slower recovery from a depres-
sive episode [36].  
  Women are approximately three times more likely to 
develop depression in response to stress because they experi-
ence more stressful events [30, 37-39]. Women report more 
depressive symptoms than men, with an emphasis on worth-
lessness, decreased sexual interest, guilt feelings, insomnia, 
anxiety, and gastrointestinal symptoms [36, 40]. This promi-
nent gender difference in depression begins in adolescence, 
prior to which the incidence of major depression is equal in 
girls and boys, suggesting the potential role of female sex 
hormones in female depression vulnerability [41]. Many 
depressed women also exhibit anxiety symptoms, and it has 
been suggested that women may be more likely to suffer 
from mixed anxiety-depressive disorder [42, 43]. Polymor-
phic variations in 5-HT transporter, MAO-A or 5-HT recep-
tor may be involved in the sex related differences of adapta-
tion to stress [29]. 
3. STRESS CONTROLLABILITY AND LEARNED 
HELPLESSNESS IN ANIMAL MODELS  
  Based upon the clinical evidence that links stressful life 
events with depressive episodes several animal models ex-
hibiting stressor controllability and learned helplessness have 
been developed [44-47]. The most common animal model of 
'stress and coping' is that of 'learned helplessness' [48, 49] in 
which animals are exposed to either controllable or uncon-
trollable stressful events and later, they are tested on a new 
task in which all animals are given the opportunity to control 
the stressor, usually by escape. In most reports, animals that 
are exposed to uncontrollable stressful events do not learn to 
escape during testing on the new task [50, 51]. This behavior 
has been equated with a sense of 'giving up', experienced by 
humans with major depression [52].  
  Animal models of depression should fulfill three major 
criteria [47]. The first criterion “face validity” assesses how 
well the symptoms observed in animals resemble those in 
human patients. The second criterion “predictive validity” 
addresses the question how well animals in the model re-
spond favorably to the same drugs as human do under the 
same treatment conditions. The third criterion “construct 
validity” assesses to what extent the model is consistent with 
the theoretical rationale.  
  The learned helplessness paradigm was not developed to 
provide an animal model of depression or anxiety but it was 
shown in later studies that the model is sensitive to both an-
tidepressants [53, 54] and anxiolytics [55-58]. Implications 
for the learned helplessness paradigm as an animal model of 
either depression or anxiety have been discussed [45,59]. 
The paradigm is widely used to understand neural mecha-
nism and degree of behavioral adaptation to an uncontrolla-
ble stressor [60-63]. 
  Animals exposed to other unpredictable and uncontrolla-
ble stressor e.g. restraint stress, elevated platform and forced 
swimming also show coping deficits for aversive but escap-
able situations [64, 65]. Chronic mild stress also causes be-
havioral changes in animals that parallels symptoms of de-
pression [66, 67].  
4. SEX RELATED DIFFERENCES IN ADAPTATION 
TO STRESS 
  Although learned helplessness is an established model for 
clinical depression and anxiety, and has been investigated for 
about 40 years, only few studies have used female animals in 
the learned helplessness paradigm. The female preponder-
ance of depression is also, heretofore, not been consistently 
reflected in animal models (Table 1). Surprisingly, evidence 
Table 1.  Sex Related Differences in Stress-Induced Behavioral Deficits 
Stressor Behavior  Behavioral  Deficits  References 
Forced swimming  Latency and duration of immobility  Male > Female  [75-79] 
Open space swimming  Latency and duration of immobility  Young Female > Young Male  [80] 
Escapable shock 
Inescapable shock 
Escape latency 
Escape impairment 
Male> Female 
Male > Female 
Male = Female 
[73] 
[69-71, 73] 
[72] 
Chronic mild stress  Disruption of sucrose intake & open field activity  Female > Male  [67, 84] 
Chronic mild stress + Forced swimming  Latency and duration of immobility  Male > Female  [67, 84] 
Single 2h restraint  Open field activity  Male > Female  [74, 82] 
Repeated restraint   Open field activity  Female > Male   [74, 82] 
Lipopolysaccharide challenge  Open field activity  
& Forced swim test 
Male > Female 
Male > Female 
[81] 
[81] 
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from animal studies suggests that females are relatively re-
sistant to the behavioral effects of an acute stress compared 
to males.  
  Exposure to inescapable foot shock disrupted shuttle box-
escape performance of males, whereas, escape performance 
of females was unaffected [68]. Escape latencies increased in 
both males and females but the increases were greater in 
male rats [69]. In the elevated plus-maze also, exposure to 
inescapable foot shock resulted in suppression of “total 
number of arm entries” and “rearings” in males but not in 
females [70]. In addition “time on open arms” was reduced 
in both sexes, but this effect was stronger in males than in 
females. No sex based difference was found in learned help-
lessness behavior in another study [71] which reported that 
females to be more vulnerable than males to stress-induced 
elevations in homocysteine but not escape deficits.  
  Exposure to controllable stress (escapable foots hock) 
alleviated the expression of helplessness behavior in both 
females and males, but females learned to escape more rap-
idly than did males [72]. Moreover, modulation of controlla-
bility i.e exposure to inescapable foot shock produced help-
less behavior in males but females were less likely to be-
come helpless [72].  
  Male rats were more vulnerable to restraint stress than 
that of the female rats because open field behavior of female 
rats was less affected by a single 2h restraint stress than that 
of the male rats, though food intake was comparably de-
creased [73]. Male animals exhibited more immobility than 
females in the forced swimming test [3, 74-78] but young 
female rats were more vulnerable than males in an open 
space swim test [79]. 
  Male rats were also more vulnerable to a mild lipopoly-
saccharide (LPS) challenge than that of female rats as as-
sessed in both forced swim and open field test [80] because 
LPS challenge decreased open field activity in male but not 
female rats. LPS-treated female rats coped better with the 
stressful forced swimming procedure, as evidenced by an 
increase in swimming duration while in males swimming 
duration was not altered by LPS administration [80]. 
  In striking contrast female but not male rats exhibited 
deficits of open field behavior after exposure to repeated 
restraint stresses [64, 73, 81, 82]. Female rats were more 
vulnerable to chronic mild stress as depicted by the disrup-
tion of sucrose intake and decreases of open field activity 
[66]. But in response to an additional forced swim test, fe-
males previously exposed to chronic mild stress, were found 
to cope better than males. The sex differences in helplessness 
behavior were not dependent on the presence of sex hor-
mones in adulthood, because neither ovariectomy of females 
nor castration of males abolished those [83]. 
  In general sex related studies on animal models show that 
female performance though better than males if exposed to 
an acute stressor but repeated or chronic exposure induces 
coping deficits to impair adaptation making female sex more 
vulnerable to depression. Data in Fig. (1) (Haleem unpub-
lished data), similar to previously reported studies [64, 73, 
81] show that male and female rats exposed to 2h restraint 
stress exhibited a decrease in open field activity monitored 
on the following day but the decreases were smaller and not 
significant in female rats. These differences were not attrib-
utable to the effects of entrained oestrus cycles in females as 
these were randomly distributed [73, 81]. Conversely, fol-
lowing repeated (2h/day for 5 days) exposure to restraint 
stress the deficits of open field exploration were present in 
female but not male rats (Fig. 1). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (1). Activity of male and female rats in an open field 24 h after 
a single (2h) or repeated (2h/day for 5 days) restraints. Male (body 
weights 200-250 gm) and female (body weights 190-230) animals 
were restrained for 2h on wire grids and activity in an open field 
was monitored 24 h after the termination of the 1
st or 5
th restraint 
period as described by Haleem & Parveen (1994). Values are means 
+ S. D. (n=6). Significant differences by Newman Keuls test: 
*P<0.01 from respective unrestrained animals; +P<0.01 from 1
st 
day (2h/day) restrained animals, following two way ANOVA. 
(Haleem unpublished data). 
5. RAPHE-HIPPOCAMPAL SEROTONIN NEURO-
TRANSMISSION AND ADAPTATION TO STRESS 
  Early indications that central serotonin system may be 
involved in responses to stress came from studies on male 
rats demonstrating that acute stress procedures like immobi-
lization, forced swimming and cold exposure increased brain 
5-HT metabolism [84, 85]. Since then evidence has accumu-
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to various stressors including exercise and foot shock al-
though brain levels of 5-HT are not always altered [1, 4, 86-
88]. It has been also shown that stress-induced increases of 
brain serotonin are caused by an increase in the availability 
of tryptophan [86, 88], the precursor of 5-HT, or an increase  
in the activity of tryptophan hydroxylase [89-92], the   
rate limiting enzyme of 5-HT biosynthesis. Microdialysis 
studies showed an increase in extracellular levels of   
serotonin [93-95] in different areas of the brain following 
exposure to different types of stressors. 
  A role of hippocampus in responses to stress, first re-
ported from our laboratory [90], also emerged from studies 
on male rats. We found that acute exposure to an episode of 
2h restraint stress increased 5-HT turnover in the hypothala-
mus, midbrain and cortex but the increases did not occur in 
the hippocampus [90]. Conversely, repeated daily exposure 
to 2h/day restraint, which produced behavioral adaptation, 
increased 5-HT turnover in the hippocampus only and not in 
other brain regions. It was suggested that an increase in sero-
tonin neurotransmission via hippocampus is involved in ad-
aptation to stress. 
  Later studies, performed on male animals, also consis-
tently showed that hippocampus may mediate adaptation to 
severe inescapable stressor by the facilitation of serotonergic 
neurotransmission (Table 2). Acute exposure to an elevated 
platform enhanced 5-HT overflow in the prefrontal cortex 
but not dorsal hippocampus whereas repeated daily exposure 
to the same stressor increased extracellular 5-HT in the dor-
sal hippocampus but not the prefrontal cortex [65]. In an-
other study rats received inescapable foot shock and were 
tested in a shuttle box 24 h later. Pre stressed animals exhib-
ited impairment of escape responses. This effect was pre-
vented by bilateral intra hippocampal injection of zimelidine, 
a serotonin reuptake blocker but not by desipramine, a 
noradrenaline reuptake blocker [96]. Neurogenesis in the 
dentate gyrus of the hippocampus was enhanced by the acti-
vation of serotonin receptors [97]. It was suppressed by 
stress and the suppression prevented by 5-HT-1A receptor 
agonists [98]. 
  The synthesis and release of 5-HT in all brain regions 
including the hippocampus [20-22, 99] is under the control 
of an effective feedback mechanism involving the stimula-
tion of 5-HT-1A receptors located on the soma and dendrites 
[100] of the serotonergic neurons in the raphe nucleus. 5-
HT1B receptors located at the terminal ends of the seroton-
ergic neurons [101] also control the release of 5-HT via a 
feedback mechanism [102]. Studies on the mechanism of 
action of selective serotonin reuptake inhibitors (SSRIs) and 
other antidepressants showed that repeated administration of 
these drugs increased 5-HT neurotransmission by either de-
creasing the sensitivity of presynaptic receptor or increasing 
the sensitivity of postsynaptic 5-HT-1A receptor in the dor-
sal hippocampus [13, 14, 16, 103]. Consequently it was sug-
gested that a decrease in the function of the 5-HT in the hip-
pocampus and an increased function of the 5-HT-1A recep-
tor in the raphe nucleus coexist in depression.  
  Studies using learned helplessness model of anxiety/ 
depression and chronic stress model of depression also sup-
port the role of 5-HT-1A receptor in adaptation to stress. 
Thus, rats adapted to repeated restrain stress schedule of 
2h/day for 5 days exhibited a decrease in the sensitivity of 
somatodendritic 5-HT-1A [60, 104] and terminal 5-HT-1B 
[105] receptors: an effect similar to antidepressant like ef-
fect. It was suggested that a decrease in the negative feed-
Table 2.  Evidence that Facilitation of Serotonin Neurotransmission in the Hippocampus is Involved in Adaptation to Stress 
Challenge Response  Hippocampal  5-HT  References 
Restraint stress  Decrease in food intake &  
open field activity  
5-HT increased in many brain regions except the hippocampus  [91] 
Repeated restraint  Normal food intake &  
open field activity 
5-HT increased only in the hippocampus  [91] 
Acute exposure to elevated 
platform 
Increase in plasma corticosterone   Extra cellular 5-HT increased in the frontal cortex but not the 
hippocampus  
[66] 
Repeated daily (10 days) 
exposure to elevated  
platform 
Normal plasma  
corticosterone response  
Extra cellular 5-HT increased in the  
hippocampus but not the frontal cortex 
[66] 
Inescapable foot shock  Escape impairment in shuttle box   The behavioral deficit normalized with bilateral intra  
hippocampal serotonin reuptake inhibitor 
[97] 
Subordination stress  Neurogenesis   Stress-induced suppression of neurogenesis in the hippocampus 
prevented by 5-HT-1A agonists 
[98-99] 
Forced swimming  Immobility  Decreased 5-HT-1A receptor binding  in the hippocampus  [125] 
Restraint stress  Feedback control over 5-HT   Exaggerated feedback control over hippocampal 5-HT  [107] 
Restraint stress  Density of 5-HT-1A receptor  5-HT-1A receptor binding decreased in the hippocampus   [99, 110, 119] 
Unpredictable, mild to 
moderate stressors 
5-HT-1A mRNA  5-HT-1A expression decreased in the hippocampus  [23] 
Long term administration 
of SSRIs 
Feedback control over 5-HT  Smaller feedback effects over hippocampal 5-HT  [13, 14, 104]  516    Current Neuropharmacology, 2011, Vol. 9, No. 3  Darakhshan Jabeen Haleem 
back control due to desensitization of auto receptors   
increases the availability of 5-HT in terminal regions to   
help cope the stress demand and produce adaptation to stress 
(Fig 2). Conversely, exposure to inescapable but not escap-
able stressors sensitized serotonergic neurons in the raphe 
region to subsequent input [85]. Acute exposure to 2h   
restraint stress [106] as well as long term starvation [107] 
increased the responsiveness of somatodendritic 5-HT-1A 
receptor to decrease serotonin neurotransmission particularly 
via raphe-hippcampal pathway (Fig. 2). A decrease in the 
density of 5-HT-1A receptor in the hippocampus also oc-
curred in rats exposed to restraint stress [98, 108, 109]. Rats 
exposed to different mild to moderate stressors every day, 
therefore making the daily stress exposure unpredictable 
exhibited a significant decrease in 5-HT-1A mRNA and   
5-HT-1A receptor binding in the hippocampus [23].  
  It may be argued that a desensitization and super sensiti-
zation respectively of autoreceptors would be expected to 
increase and decrease the availability of 5-HT in all brain 
regions innervated by serotonergic neurons and not particu-
larly in the hippocampus [90]. An explanation to this could 
be that postsynaptic 5-HT-1A receptors also control the   
synthesis and release of 5-HT via feedback mechanism.   
Hippocampus is enriched with 5-HT-1A receptor [110] and 
receives serotonergic innervations from median raphe [111]. 
Many innervated areas project back to raphe nuclei and   
these are interconnected [112]. It is therefore possible   
that postsynaptic 5-HT-1A receptors also alter the median 
raphe nucleus 5-HT neuronal firing [15]. It is also possible 
that the effects are mediated via stress-induced release of 
corticosteroid hormones. Hippocampus is enriched with high 
affinity mineralocorticoid receptors and lower affinity gluco-
corticoid receptors at which corticosteroids bind to alter   
5-HT-1A receptor mediated responses, reviewed by Joel, 
[113]. 
6. SEX-DIFFERENCES IN RAPHE-HIPPOCAMPAL 
SEROTONIN NEUROTRANSMISSION 
  If facilitation of serotonin neurotransmission due to de-
sensitization of somatodendritic 5-HT-1A receptor increas-
ing the availability of 5-HT in the hippocampus mediates 
adaptation to stress, the sex differences of somatodendritic 5-
HT-1A receptors become important. Sexual dimorphism in 
the serotonin was first reported in early 1960’s [114]. An 
increasing amount of later work supported the view that cen-
tral serotonin metabolism synthesis and functional responses 
are greater in female than male rats [20, 115-117]. It was 
also observed that sex differences of 5-HT were particularly 
larger in the hippocampus [20]. 
  Sex differences also occur in the regulation of serotonin 
neurotransmission via 5-HT-1A receptors [118]. Expression 
of serotonin-1A receptor messenger RNA was greater in 
males in the hypothalamus and amygdala, and less in males 
in the hippocampus [119]. The concentrations of 5-HT and 
5-HIAA were greater in the hippocampus of female than 
male rats. The 5-HT-1A agonist 8-hydroxy-2 (di-n-
propylamino) tetralin caused comparable decreases of 5-HT 
and 5-HIAA in both sexes in the hypothalamus, cortex and 
midbrain except the hippocampus where the decreases were 
twice as large in the females as in males [20]. It suggests  
that the sensitivity of 5-HT-1A receptors that control the 
availability of 5-HT in the hippocampus (Fig. 2) is greater in 
female sex.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (2). Attenuation (red) and enhancement (green) of raphe-hippocampal serotonin neurotransmission regulated by somatodendritic 5-HT-
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  A few studies have examined sex influence on the role of 
hippocampus in responses to stress. Female in proestrus ex-
hibited greater density of dendritic spines in the area CA1 of 
the hippocampus than males [120]. In response to acute 
stressful event of intermittent shocks, spine density was en-
hanced in the male hippocampus but reduced in the female 
hippocampus. Effects of early experience on the dendritic 
structure of dentate gyrus were also sexually dimorphic 
[121]. Thus female rats raised in an enriched environment 
displayed increased dendritic bushiness relative to males 
raised in the same environment. Conversely, neonatal han-
dling resulted in an increase in postsynaptic serotonin neuro-
transmission in the hippocampus of male rats but decreased 
it in females [122]. LPS treatment induced a female-specific 
enhancement of 5-HIAA levels in the hippocampus and 
some other regions [80]. 
  In a study of sex influence and isolation housing on 5-
HT-1A receptor binding female mice displayed lower post-
synaptic 5-HT-1A receptor binding compared to males in the 
hippocampus. Subsequently, following 6 weeks isolation 
housing 5-HT-1A receptor binding was further increased in 
males but not in females [123]. Conversely, forced swim-
ming was found to decrease 5-HT-1A receptor binding in the 
hippocampus of female but not male rats [124]. Serotonin-
1A mRNA, protein and binding sites, were greater in the 
hippocampi of pre-pubertal female than male rats. These 
were decreased more by neonatal handling and the decreases 
were greater in female sex [122].  
  Sex related studies therefore show that male and female 
animals have different levels of serotonin neurotransmission 
via raphe- hippocampal pathway under unstressed condition, 
which can respond in opposite directions to the same stres-
sor. Females have greater serotonin content but an exagger-
ated feedback control over raphe-hippocampal serotonin 
neurotransmission  via 5-HT-1A receptors making this sex 
more vulnerable to depression.  
  It is worth considering that serotonin functions are modu-
lated by corticosteroids [113, 125, 126] while stress-induced 
[81] as well as 5-HT-1A agonist-induced [82] increase of 
plasma corticosterone, the principal corticosteroid secreted 
by the rat adrenal gland, are greater in female than male rats 
suggesting an important role of circulating corticosteroids in 
the sex related differences of raphe hippocampal serotonin 
neurotransmission in adaptation to stress. Influence of MAO-
A genotype on 5-HT-1A receptor availability or polymorphic 
variations of 5-HT transporters [108] may well be involved 
in these sex differences of 5-HT-1A expression. 
  5-HT-1A receptor dependent responses are also modu-
lated by estrogen. Thus, acute estrogen treatment prevented 
5-HT1A receptor-induced disruption of Prepulse inhibition 
in healthy women [127]. Although, estrogen treatment to 
ovariectomized rats had no effect on the number or affinity 
of 5-HT1A binding sites labeled with [
3H]8-OH-DPAT but 5-
HT1A-mediated inhibition of adenylate cyclase selectively 
increased in the hippocampus [128]. A role of glutamate 
receptors in the sex related differences of adaptation to stress 
is also possible because antidepressant like activity of chro-
mium chloride in the forced swim test in mice was inhibited 
by antagonists of glutamate receptors as well as antagonists 
of 5-HT-1A receptors [129]. 
7. POSSIBLE CLINICAL RELEVANCE  
  There is wealth of clinical evidence supporting sex dif-
ference in 5-HT-1A receptor function. Investigations have 
also been made to show that variation in 5-HT-1A expres-
sion is genetically mediated [130, 131]. 
  Age related sexual dimorphism of 5-HT-1A receptor 
binding potential was initially observed in various brain tis-
sues obtained from autopsy subjects. In this study men ex-
hibited a significant age dependent decrease in the dissocia-
tion constant (Kd) for 5-HT-1A receptor binding in the oc-
cipital cortex; in women maximum binding capacity (Bmax) 
decreased with aging in the parietal cortex and hippocampus 
[132].  
 Parsey  et al. [133] did not find an age related decrease in 
5-HT-1A binding potential in healthy men or women. How-
ever, they found higher 5-HT-1A binding potential in the 
dorsal raphe and many forebrain regions of women than 
men. Conversely, 5-HT-2 receptor binding capacity was 
higher in healthy men than healthy women [134]. Staley   
et al. [135] observed higher 5-HT transporter availability in 
healthy women than men, but lower 5-HT transporter avail-
ability in depressed women than depressed men [136]. 
Javanovic et al. [137] also observed that compared to healthy 
men healthy women had significantly higher 5-HT-1A recep-
tor but lower 5-HT transporter binding potential in a wide 
array of cortical and subcortical brain regions but in the fol-
licular phase, women did not differ from men in the 5-HT1A 
receptor binding [138]. 
  Several strands of evidence have emerged that specifi-
cally implicate 5-HT-1A receptors in depression and thera-
peutic effects of antidepressant drugs. Men and women pa-
tients with major depression exhibited attenuation of 5-HT-
1A receptor mediated neuroendocrine and hypothermic re-
sponses reflecting a decrease in the effectiveness of postsyn-
aptic and somatodendritic 5-HT-1A receptors respectively 
[46, 139, 140]. A decrease in 5-HT-1A binding potential has 
been also observed in the multiple brain areas including ra-
phe region of men and women patients with major depres-
sion and bipolar disorder [141-143]. In another study, pa-
tients with major depression who have never been exposed to 
medication were found to have higher 5-HT-1A receptor 
binding compared to the depressed patients with a history of 
medication and control [133] suggesting the 5-HT-1A bind-
ing potential to be affected by medication. Higher 5-HT1A 
binding potential in the raphe and hippocampus in bipolar 
depressed males but not in bipolar depressed females has 
been also reported [68]. 
  Currently the most common class of effective antidepres-
sants is SSRIs that acts by selectively blocking the high af-
finity reuptake of serotonin. Approximately 78% of the pre-
scribed SSRIs are given to women [5], while some studies 
indicate that sex may moderate the response to antidepres-
sants with women exhibiting a preferential response to 
SSRIs compared to TCAs. Investigations addressing gender 
differences in response to SSRI (sertraline) and imipramine 
treatment in male and female patients with chronic depres-
sion have reported that premenopausal women had a favor-
able response to sertraline than to imipramine [17, 144]. 
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two medications and men exhibited a more favorable re-
sponse to impramine than to sertraline. Martenyi et al. [145] 
compared treatment efficacy of SSRI (fluoxetine) and SNRI 
(maprotiline) in men and women patients of unipolar depres-
sion. They found a significant difference between treatment 
groups in females but not in males. Amongst females the 
difference was significant in women aged <44 years but not 
>44 years suggesting that women in their reproductive pe-
riod are more responsive to SSRIs than SNRIs. In a recent 
study, Young et al. [146] have reported that women have a 
better response to the SSRI citalopram than men, which may 
be due to sex-specific biological differences particularly in 
serotonergic systems.  
CONCLUSION 
  The evidence accumulated in the present article suggests 
that raphe hippocampal serotonin neurotransmission and its 
regulation by 5-HT-1A receptors has an important role in the 
sex related differences of adaptation to stress. Greater 5-HT 
neurotransmission  via postsynaptic 5-HT-1A receptors in   
the hippocampus makes female sex more resistant to an 
acute stressor. On the other hand, greater efficacy of   
feedback control over 5-HT synthesis and release mediated 
via 5-HT-1A receptors could impair adaptation making the 
female sex more vulnerable to repeated and/or chronic stres-
sors. In the quest to understand the mechanism of sex related 
differences in adaptation to stress, the role of raphe-
hippocampal serotonin neurotransmission and its regulation 
by 5-HT-1A receptors can only be a small part of a big   
picture. The mechanisms through which estrogen and   
glucocorticoids can modulate serotonin neurotransmission 
and functional polymorphisms in the 5-HT transporter gene 
are also worth considering for an understanding of sex   
related differences of adaptation to stress. Despite height-
ened complexity it implies that the issue of sex related   
differences of brain function is not less important because  
it may provide ways to understand novel mechanisms of 
brain function.  
ACKNOWLEDGEMENT 
  The author would like to thank Higher education   
Commission, Pakistan Science Foundation and Karachi   
University for providing research grants. 
REFERENCES 
[1]  Andrews, M.H.; Matthews, S.G. Programming of the Hypo-
thalamo-Pituitary-Adrenal Axis: Serotonergic Involvement. Stress, 
2004, 7, 15-27. 
[2]  Jans, L.A.; Riedel, W.J.; Markus, C.R.; Blokland, A. Serotonergic 
vulnerability and depression: assumptions, experimental evidence 
and implications. Mol. Psychiatry, 2007, 12, 522-543. 
[3]  Vigod, S.N.; Stewart, D.E. Emergent research in the cause of men-
tal illness in women across the life span. Curr. Opin. Psychiatry, 
2009, 22, 396-400. 
[4]  Bebbington, P.; Dunn, G.; Jenkins, R.; Lewis, G.; Brugha, T.;   
Farrell, M.; Meltzer, H. The influence of age and sex on the   
prevalence of depressive conditions: report from the National   
Survey of Psychiatric Morbidity. Int. Rev. Psychiatry, 2003, 15, 74-83.  
[5]  Kessler, R. C. Epidemiology of women and depression. J. Affect. 
Disorder, 2003, 74, 5-13. 
[6]  Kornstein, S.G.; Schatzberg, A.F.; Thase, M.E.; Yonkers, K.A.; 
McCullough, J.P.; Keitner, G.I; Gelenberg, A.J.; Ryan, C.E.; Hess, 
A.L.; Harrison, W.; Davis, S.M.; Keller, M.B.; Gender differences 
in chronic double and major depression. J. Affect. Disorder, 2000, 
60, 1-11. 
[7]  De Vries, G.J. Sex differences in adult and developing brain: Com-
pensation, compensation, compensation. Endocrinology, 2004, 145, 
1063-1068. 
[8]  Hoyer, D.; Hannon, J.P.; Martin, G.R. Molecular pharmacological 
and functional diversity of 5-HT receptors. Pharmacol. Biochem. 
Behav., 2002, 71, 533-554. 
[9]  Christiansen, L.; Tan, Q.; Iachina, M.; Bathum, L.; Kruse, T.A.; 
McGue, M.; Christensen, K. Candidate gene polymorphisms in the 
serotonergic pathway: influence on depression symptomlogy in an 
elderly population. Biol. Psychiatry, 2007, 61, 223-230. 
[10]  McMahon, F.J.; Buervenich, S.; Charney, D.; Lipsky, R.; Rush, 
A.J.; Wilson, A.F.; Sorant, A.J.; Papanicolaou, G.J.; Laje, G.; Fava, 
M.; Trivedi, M.H.; Wisniewski, S.R.; Manji, H. Variation in the 
gene encoding the serotonin-2A receptor is associated with out-
come of antidepressant treatment. Am. J. Hum. Genet., 2006, 78, 
804-814. 
[11]  Niesler, B.; Kapeller, J.; Hammer, C.; Rappold, G. Serotonin type 3 
receptor genes: HTR3A, B, C, D, E. Pharmacogenomics, 2008, 9, 
501-504. 
[12]   Savitz, J.; Lucki, I.; Drevets, W.C. 5-HT-1A receptor function in 
major depressive disorder. Prog. Neurobiol., 2009, 88, 17-31. 
[13]  Artigas, F.; Bel, N.; Casanovas, J.M.; Romero, L. Adaptive 
changes of the serotonergic system after antidepressant treatments. 
Adv. Exp. Med. Biol., 1996, 398, 51-59. 
[14]  Barton, C.L.; Hutson, P.H. Inhibition of hippocampal 5-HT synthe-
sis by fluoxetine and paroxetine: evidence for the involvement of 
both 5-HT-1A and 5-HT1B/D autoreceptors. Synapse,  1991,  31, 
13-19. 
[15]  Blier, P.; de Montigny, C. Modification of 5-HT neuron properties 
by sustained administration of the 5-HT-1A agonist gepirone: elec-
trophysiological studies in the rat brain. Synapse, 1987, 1, 470-480. 
[16]  Gardier, A.M.; Wurtman, R.J. Persistent blockade of potassium-
evoked serotonin release from rat frontocortical terminals after 
fluoxetine administration. Brain Res., 1991, 540, 325-330. 
[17]  Kornstein, S.G.; Schatzberg, A.F.; Thase, M.E.; Yonkers, K.A.; 
McCullough, J.P.; Keitner, G.I.; Gelenberg, A. ; Davis, S.D.; 
Harrison, W.H.; Keller, M.B. Gender differences in treatment re-
sponse to sertraline versus imipramine in chronic depression. Am. 
J. Psychiatry, 2000, 157, 1445-1452. 
[18]  Lesch, K.P.; Gutknecht, L. Focus on the 5-HT-1A receptor:   
emerging role of a gene regulatory variant in psychopathology   
and pharmacogenetics. Int. J.  Neuropsychopharmacol.,  2004,  7, 
381-385. 
[19]  Sharp, T.; Boothman, L.; Raley, J.; Queree, P. Important measures 
in the post recent discoveries in 5-HT neuron feedback control. 
Trends Pharmacol. Sci., 2007, 28, 629-636. 
[20]  Haleem, D.J.; Kennett, G.A.; Curzon, G. Hippocampal 5-HT   
synhesis is greater in females than in males and is more decreased 
by 5-HT-1A agonist 8-OH-DPAT. J. Neural Transm.,  1990,  79, 
93-101. 
[21]  Hutson, P.H.; Dourish, C.T.; Curzon,G. Neurochemical and behav-
ioral evidence for mediation of the hyperphagic action of 8-OH-
DPAT by cell body autoreceptors. Eur. J. Pharmacol., 1986, 129, 
347-352. 
[22]  Sharp, T.; Bramwell, S.R; Hjorth, S.; Grahame-Smith, D.J. 
Pharmacological characterization of 8-OH-DPAT-induced 
inhibition of rat hippocampal 5-HT release in vivo as measured by 
microdialysis. Br. J. Pharmacol., 1989, 98, 989-997. 
[23]  Lopez, J.F.; Chalmers, D.; Little, K.Y.; Watson, S.J. Regulation   
of 5-HT-1A receptor, glucocorticoid mineralocorticoid receptor in 
rat and human hippocampus: implications for the neurobiology of 
depression. Biol. Psychiatry, 1998, 43, 547-573. 
[24]  McEwen, B.S. Stress and hippocampal plasticity. Ann. Rev.   
Neurosci., 1999, 22, 105-122. 
[25]  McEwen, B.S. The neurobiology of stress: from serendipity to 
clinical relevance. Brain Res., 2000, 886, 172-189. 
[26]  Anisman, H. Cascading effects of stressors and inflammatory im-
mune system activation: implication for major depressive disorder. 
Rev. Psychiatr. Neurosci., 2009, 34, 4-20. 
[27]  Bale, T.L. Stress sensitivity and the development of affective dis-
orders. Horm. Behav., 2006, 50, 529-533. 
[28]  Gilbert, G.; Gilbert, J.; Irons, C. Life events, entrapments and   
arrested anger in depression. J. Affect. Disorder, 2004, 79, 149-160. 
[29]  Jabbi, M.; Korf, J.; Ormel, J.; Kema, I.P.; Den Boer, J.A. Investi-
gating the molecular basis of major depressive disorder etiology, A Sex Differences: Raphe-Hippocampal Serotonin  Current Neuropharmacology, 2011, Vol. 9, No. 3    519 
functional convergent genetic approach. Stress, neurotransmitter 
and hormones. Ann. NY. Acad. Sci., 2008, 1148, 42-56. 
[30]  Kendler, K.S.; Kuhn, J.; Prescott, C.A. The relationship of neuroti-
cism, sex and stressful life events in the prediction of episodes of 
major depression. Am. J. Psychiatry, 2004, 161, 631-636. 
[31]  Keller, M.C.; Neale, M.C.; Kendler, K.S. Association of deifferent 
adverse life events with distinct pattern of depressive symptoms. 
Am. J. Psychiatry, 2007, 164, 1521-1529. 
[32]  Bromberger, J.T.; Kravitz, H.M.; Matthews, K.; Youk, A.; Brown, 
C.; Feng, W. Predictors of first life time episodes of major depres-
sion in midlife women. Psychol. Med., 2009, 39, 55-64. 
[33]  Kessler, R.C. The effects of life events on depression. Ann. Rev. 
Psychol., 1997, 48, 191-214. 
[34]  Oquendo, M.; Ellis, S.; Greenwald, S.; Malone, K..; Weissman, M.; 
Mann, J. Ethnic and sex differences in suicide rates relative to ma-
jor depression in the United States. Am. J. Psychiatry, 2001, 158, 
1652-1658. 
[35]  Kessler, R.; McGonagle, K.; Swartz, M.; Blazer, D.; Nelson, C. 
Sex and depression in the National Comorbidity Survey, I: Life-
time prevalence, chronicity and recurrence. J. Affect. Disord., 1993, 
29, 85-96. 
[36]  Ernst, C.; Angst, J. The Zurich Study XII: Sex differences in   
depression: Evidence from longitudinal epidemiological data. Eur. 
Arch. Psychiatry Clin. Neurosci., 1992, 241, 222-230. 
[37]  Kendler, K.S.; Thrornton, L.M.; Gardner, C.O. Stressful life events 
and previous episodes in the etiology of major depression in 
women: an evaluation of the “kindling” hypothesis. Am. J. Psychia-
try, 2000, 157, 1243-1251. 
[38]  Maciejewski, P.; Prigerson, H.; Mazure, C. Sex differences in 
event-related risk for major depression. Psychol. Med., 2001, 31, 
593-604. 
[39]  Mazure, C.; Maciejewski, P. The interplay of stress, gender and 
cognitive style. Arch. Women Ment. Health., 2003, 6, 5-8. 
[40]  Silverstein, B. Gender differences in the prevalence of clinical 
depression: The role played by depression associated with somatic 
symptoms. Am. J. Psychiatry, 1999, 156, 480-482. 
[41]  Payne, J.L. The role of estrogen in mood disorder in women. In-
tern. Rev. Psychiatry, 2003, 15, 280-290. 
[42]  Lewinsohn, P.M.; Rohde, P.; Seeley, J.R.; Baldwin, C.L. Gender 
differences in suicide attempts from adolescence to young adult-
hood. J. Am. Acad. Child Adolesc. Psychiatry, 2001, 40, 427-434. 
[43]   Piggot,T. A. Gender differences in the epidemiology and treatment 
of anxiety disorders. J. Clin. Psychiatry, 1999, 60(Suppl 18), 4-15. 
[44]  Chourbaji, S.; Zacher, C.; Sanchis-Sequra, C.; Dormann, C.; Voll-
mayr, B.; Gass, P. Learned helplessness: validity and reliability of 
depressive like states in mice. Brain Res. Brain Res. Protoc., 2005, 
16, 70-78. 
[45]  Maier, S.F.; Watkin, L.R. Stressor controllability and learned help-
lessness: The roles of the dorsal raphe nucleus, serotonin, and cor-
ticotrophin releasing factor. Neurosci. Biobehav. Rev.,  2005,  29, 
829-841. 
[46]  Shapira, B.; Newman, M. E.; Gelfin, Y.; Lerer, B. Blunted tem-
perature and cortisol response to ipsapirone in major depression: 
lack of enhancement by electroconvulsive therapy. Psychoneu-
roendocrinology, 2000, 25, 421-438. 
[47]  Willner, P. The validity of animal model of depression. Psycho-
pharmacology, 1984, 83, 1-16. 
[48]  Maier, S.F. Learned helplessness and animal models of depression. 
Prog. Neuropsychopharmacol. Biol. Psychiatry, 1984, 8, 435-446. 
[49]   Seligman, M. E.; Beagley, G. Learned helplessness in the rat. J. 
Comp. Physiol. Psychol., 1975, 88, 534-541.  
[50]  Overmier, J.B.; Seligman, M. E. Effects of inescapable shock upon 
subsequent escape and avoidance responding. J. Comp. Physiol. 
Psychol., 1967, 63, 28-33. 
[51]   Seligman, M. E.; Maier, S. F. Failure to escape traumatic shock. J. 
Exp. Psychol., 1967, 74, 1-9. 
[52]  Miller, W.R.; Seligman, M.E. Depression and learned helplessness 
in man. J. Abnorm. Psychol., 1975, 84, 228-238.  
[53]  Gambarana, C.; Scheggi, S.; Tagliamonte, A.; Pierluigi, T.; De 
Montis, M.G. Animal models for the study of antidepressant activ-
ity. Brain Res. Brain Res. Protoc. 2001, 7, 11-20. 
[54]  Petty, F.; Davis, L.L.; Dabel, D.; Kramer, G.L. Serotonin dysfunc-
tion disorders: a behavioral neurochemistry perspective. J. Clin. 
Psychiat. 1996, 57, 11-16. 
[55]  Drugan, R.C.; Ryan, S.M.; Minor, T.R.; Maier, S.F. Librium   
prevents the analgesic and shuttlebox escape deficits typically   
observed following inescapable shock. Pharmacol. Biochem.   
Behav., 1984, 21, 749-754. 
[56]  Maier, S.F.; Kalman, B.A.; Sutton, L.C.; Wiertelak, E.P.; Watkin, 
L.R. The role of the amygdale and dorsal raphe nucleus in mediat-
ing behavioral consequences of inescapable shock. Behav. Neuro-
sci., 1993, 107, 377-388. 
[57]  Maier, S.F.; Kalman, B A.; Grahn, R E. Chlordiazepoxide microin-
jected in the region of the dorsal raphe nucleus eliminates the inter-
ference with escape responding produced by inescacapable shock 
whether administered before inescapable shock or escape testing. 
Behav. Neurosci., 1997, 108, 121-130. 
[58]  Short, K.R.; Maier, S.F. Stressor controllability, social interaction 
and benzodiazepine systems. Pharmacol. Biochem. Behav., 1993, 
45, 827-835. 
[59]  Vollmayr, B.; Henn, F. A. Learned helplessness in the rat: im-
provements in the validity and reliability. Brain Res. Brain Res. 
Protoc., 2001, 8, 1-7. 
[60]  Haleem, D.J. Serotonergic mechanism of antidepressant action and 
adaptation to stress. J. Coll. Physician Surg. Pak., 1999, 9, 139-146. 
[61]  McArthur, R.; Borsini, F. Animal models of depression in drug 
discovery: a historical perspective. Pharmacol. Biochem. Behav., 
2006, 84, 436-452. 
[62]  Rupniak, N.M. Animal models of depression challenges for a drug 
development perspective. Behav. Pharmacol., 2003, 14, 385-390. 
[63]  Willner, P.; Mitchell, P.J. The validity of animal model of 
predisposition to depression Behav. Pharmacol., 2002, 13, 169-188. 
[64]  Kennett, G.A.; Dickinson, S.L.; Curzon, G. Enhancement of some 
5-HT dependent behavioral responses following repeated immobi-
lization in rats. Brain Res., 1985, 330, 252-263. 
[65]  Storey, J.D.; Robertson, D.A.; Beattie, J.E.; Reid, I.C.; Mitchell, 
S.N.; Balfour, D.J. Behavioral and neurochemical responses 
evoked by repeated exposure to an elevated open platform. Behav. 
Brain Res. 2006, 166, 220-229. 
[66]  Dalla, C.; Antoniou, K.; Drossopoulou, G.; Xagoraris, M.; Kokras, 
N.; Sfikakis, A.; Papadopoulou-Daifoti, Z. Chronic mild stress: are 
females more vulnerable ? Neuroscience, 2005, 135, 703-714. 
[67]  Mineur, Y.S.; Beizung, C.; Crusio, W.E. Effects of unpredictable 
chronic mild stress on anxiety and depression like behavior in 
mice. Behav. Brain Res., 2006, 75, 43-50.  
[68]  Steenbergen, H.L.; Heinssbroek, R.P.W.; Van Harren, F.; Van de 
Poll, N. E. Sex dependent effects of inescapable shock administra-
tion on behavior and subsequent escape performance in rats. 
Physiol. Behav., 1989, 45, 781-787. 
[69]  Heinsbroek, R.P.; Van Haaren, F.; Van de Poll, N.E.; Steenbergen, 
H.L. Sex differences in the behavioral consequences of inescapable 
foot shocks depend on time since shock. Physiol. Behav.,  1999, 
149,  1257-1263. 
[70]  Steenbergen, H. L.; Heinsbroek, R. P.; Van Hest, A.; Van de Poll, 
N. E. Sex-dependent effects of inescapable shock administration on 
shuttle box-escape performance and elevated plus-maze behavior. 
Physiol. Behav., 1990, 48, 571-576.  
[71]    Setnik, B.; de Souza, F G.; d’Almeida, A.; Nobrega, J.M. In-
creased homocysteine levels associated with sex and stress in the 
learned helplessness model of depression. Pharamacol. Biochem. 
Behav., 2004, 77, 155-161. 
[72]   Shors, T.J.; Mathew, J.; Sisti, H.M.; Edgecomb, C.; Beckoff, S.; 
Dalla, C. Neurogenesis and helplessness are mediated by controlla-
bility in males but not in females. Biol. Psychiatry, 2007, 62, 487-
95.  
[73]  Kennett, G.A.; Chaouloff, F.; Marcou, M; Curzon G. Female rats 
are more vulnerable than males in an animal model of depression: 
the possible role of serotonin. Brain Res., 1986, 382, 416-421. 
[74]  Alonso, S.J.; Castellano, M.A.; Rodriguez, M. Sex differences in 
behavioral despair: relationship between behavioral despair and 
open field activity. Physiol. Behav., 1991, 49, 69-72. 
[75]  Barros, H.M.; Ferigolo, M. Ethopharmacology of imipramine in the 
forced swimming test: gender differences. Neurosci. Biobehav. 
Rev., 1998, 23, 279-286. 
[76]  Contreras, C.M.; Lara-Morales, H.; Molina-Hernandez, M.; Saave-
dra, M.; Arrelin-Rosas, G. An early lesion of the lateral septal nu-
clei produces changes in the forced swim test depending on gender. 
Prog. Neuropsychopharmacol. Biol. Psychiatry,  1995,  19, 1277-
1284. 
[77]  Marvan, M.L.; Chavez-Chavez, L.; Santana, S. Clomipramine 
modifies fluctuations of forced swimming immobility in different 
phases of the rat estrous cycle. Arch. Med. Res., 1996, 27, 83-86. 520    Current Neuropharmacology, 2011, Vol. 9, No. 3  Darakhshan Jabeen Haleem 
[78]  Marvan, M.L.; Santana, S.; Chevez, L.C.; Bertran, M. Inescapable 
shocks attenuate fluctuations of forced swimming immobility in 
different phases of the rat estrous cycle. Arch. Med. Res., 1997, 28, 
369-372. 
[79]  Sun, M-K.; Alkon, D.L. Differential gender related vulnerability to 
depression induction and converging antidepressant responses in 
rats. J. Pharmacol. Exp. Ther., 2006, 316, 926-932. 
[80] Pitychoutis,  P.M.;
  Nakamura, K.; Tsonis, P.A.; Papadopoulou-
Daifoti, Z. Neurochemical and behavioral alterations in an inflam-
matory model of depression: Sex differences exposed. Neurosci-
ence, 2009, 159, 1216-1232.  
[81]  Haleem, D.J.; Kennett, G. A.; Curzon, G. Adaptation of female   
rats to stress: shift to male pattern by inhibition of corticosterone 
synthesis. Brain Res., 1988, 458, 339-347. 
[82]  Haleem, D.J.; Kennett, G.A.; Whitton, P.S.; Curzon, G. 8-OH-
DPAT increases corticosterone but not other 5-HT-1A dependent 
responses more in females. Eur. J. Pharmacol., 1989, 164, 435-
443. 
[83]  Dalla, C.; Edgecomb, C.; Whetstone, A.S.; Shors, T.J. Females do 
not express learned helplessness like males do. Neuropsychopharma-
cology, 2008, 33, 1559-1569. 
[84]  Bliss, E.L.; Ailion, J.; Zwangziger, J. Metabolism of norepineph-
rine, serotonin and dopamine in rat brain with stress. J. Pharmacol. 
Exp. Ther., 1968, 164, 122-134.  
[85]  Curzon, G.; Green, A.R. Effects of immobilization on rat brain 
tryptophan pyrrolase and brain 5-hydroxytryptamine metabolism. 
Br. J. Pharmacol., 1969, 37, 689-697. 
[86]  Chaouloff, F.; Berton, O.; Mormede P. Serotonin and stress.   
Neuropsychopharmacology, 1999, 21, 28S-32S. 
[87]  Curzon, G.; Joseph, M.H.; Knott, P.J. Effects of immobilization 
and food deprivation on rat brain tryptophan metabolism. J.   
Neurochem., 1972, 19, 1967-1974. 
[88]    Kennett, G.A; Joseph, M.H. The functional importance of   
increased brain tryptophan in the serotonergic responses to restraint 
stress. Neuropharmacology, 1981, 20, 39-43. 
[89]  Dunn, A.J. Foot shock -induced changes in brain catecholamines or 
indoleamines are not mediated by CRF or ACTH. Neurochem. Int., 
2000, 37, 61-69. 
[90]  Haleem, D.J.; Parveen, T. Effects of restraint on rat brain regional 
5-HT synthesis rate following adaptation to repeated restraint. Neu-
roReport, 1994, 5, 1785-1788. 
[91]  Shimizu,N.; Oomura, Y.; Kai, Y. Stress-induced anorexia in rats 
mediated via serotonergic mechanism in the hypothalamus. 
Physiol. Behav., 1989, 46, 835-841. 
[92]  Singh, V.B.; Onaivi, E.S.; Phan, T.H.; Boadle-Biber, M.C. The 
increase in rat cortical and midbrain tryptophan hydroxylase activ-
ity in response to acute and repeated sound stress are blocked by bi-
lateral lesions of the central nucleus of the amygdale. Brain Res., 
1990, 530, 49-50. 
[93]  Adell, A.; Casanovas, J.M.; Artigas, F. Comparative study in the 
rat of the actions of different types of stress on the release of 5-HT 
in raphe nuclei and forebrain areas. Neuropharmacology, 1997, 36, 
735-741. 
[94]  Fujino, K.; Yoshitake, T.; Inoue, O., Ibii N.; Kehr, J.; Ishida, J.; 
Nohata, H. Yamaguchi, M. Increased serotonin release in mice 
frontal cortex and hippocampus induced by acute physiological 
stressors. Neurosci. Lett., 2002, 320, 91-95. 
[95]  Shimizu, N. Take, S.; Hori, T. Oomura, Y. In vivo measurement of 
hypothalamic serotonin release by intracerebral microdialysis: Sig-
nificant enhancement by immobilization stress in rats. Brain Res. 
Bull., 1992, 28, 727-734. 
[96]  Joca, S.R.; Zanelati, T.; Guimaraes, F.S. Post stress facilitation of 
serotonergic, but not noradrenergic neurotransmission in the dorsal 
hippocampus prevented learned helplessness development in rats. 
Brain Res., 2006, 1087, 67-74. 
[97]  Jason, J.R.; Jacobs B.L. 5-HT-1A receptor antagonist administra-
tion decreases cell proliferation in the dentate gyrus. Brain Res., 
2002, 955, 264-267. 
[98]  Gould, E. Serotonin and hippocampal neurogenesis. Neuropharma- 
cology, 1991, 21(2 Suppl), 46S-51S. 
[99]  Hjorth, S.; Auerbach, S.B. Further evidence for the importance of 
5-HT-1A autoreceptors in the action of selective serotonin reuptake 
inhibitors. Eur. J. Pharmacol., 1994, 260, 251-255. 
[100]  Verge, D.; Daval, G.; Patey, A.; Gozlan, H.; Mestikawy, E.; 
Hamon, M. Presynaptic 5-HT autoreceptors on serotonergic cell 
bodies and/or dendrites but not terminals are of the 5-HT-1A sub-
type. Eur. J. Pharmacol., 1985, 113, 463-464. 
[101]  Engel, G.; Gothert, M.; Hoyer, D.; Schlicker, E.; Hillenbrand, K. 
Identity of inhibitory presynaptic 5-hydroxytryptamine autorecep-
tors in the rat brain cortex with 5-HT-1B binding sites. Naunyn-
Schmiedeberg’s Arch. Pharmacol., 1986, 332, 1-7. 
[102]   Adell, A.; Celada, P.; Artigas, F. The role of 5-HT-1B receptors in 
the regulation of serotonin cell firing and release in the rat brain. J. 
Neurochem., 2001, 79, 172-182. 
[103]  Blier, P.; Abbott, F.V. Putative mechanisms of action of antide-
pressant drugs in affective and anxiety disorder and pain. J. Psy-
chiatry Neurosci., 2001, 26, 37-43. 
[104]  Haleem, D.J. Attenuation of 8-OH-DPAT-induced decreases in 5-
HT synthesis in brain regions of rats adapted to a repeated stress 
schedule. Stress, 1999, 3, 123-129. 
[105]  Haleem, D.J.; Saify, Z.S.; Siddiqui, S.; Batool, F.; Haleem, M. A. 
Pre and post synaptic responses to 1-(1-naphthylpiperazine) follow-
ing adaptation to stress in rats. Prog. Neuropsychopharmacol. Biol. 
Psychiatry, 2002, 26, 149-156. 
[106]  Haleem, D. J.; Samad, N.; Perveen, T.; Haider, S.; Haleem, M. A. 
Role of serotonin-1A receptors in restraint -induced behavioral 
deficits and adaptation to repeated restraint stress in rats. Int. J. 
Neurosci., 2007, 117, 243-257. 
[107]  Haleem, D.J. Exaggerated feedback control over 5-HT and hyper-
activity in a rat model of anorexia nervosa. Appetite, 2009, 52, 44-
50. 
[108]  Mickey, B.J.; Ducci, F.; Hodgkinson, C.A.; Langenecker, S. A.; 
Goldman, D.; Zubieta, J-K. Monoamine oxidase a genotype   
predicts human serotonin-1a receptor availability in vivo.  J.  
Neurosci., 2008, 28, 11354 -11359. 
[109]   Wellman, C.L. Dendritic reorganization in pyramidal neurons in 
medial prefrontal cortex after chronic corticosterone administra-
tion. J. Neurobiol., 2001, 49, 245-253. 
[110]  Azmitia, E.C.; Gannon, P.J.; Kheck, N.M.; Azmitia, P.M. Cellular 
localization of 5-HT-1A receptors inn primate brain neurons and 
glial cells. Neuropsychopharmacology, 1996, 14, 35-46. 
[111]   Patel, T.B.; Azmitia, E.C.; Zhou, F.C. Increased 5-HT-1A receptor 
immunoreactivity in the rat hippocampus following 5, 7 dihydroxy-
tryptamine lesions in the cingulum bundle and fimbria fornix. Be-
hav. Brain Res., 1996, 73, 319-323. 
[112]   Jacobs, B. L.; Azmitia, E. C. Structure and function of the brain 
serotonin system. Physiol. Rev., 1992, 72, 165-229. 
[113]   Joels, M. Functional actions of corticosteroids in the hippocampus. 
Eur. J. Pharmacol., 2008, 583, 312-321. 
[114]   Kato, R. Serotonin content of rat brain in relation to sex and age. J. 
Neurochem., 1960, 5, 202P. 
[115]  Carlsson, M.; Svensson, K.; Erriksson, E.; Carlsson, A. Rat brain 
serotonin: Biochemical and functional evidence for a sex differ-
ence. J. Neural. Transm., 1985, 63, 297-313. 
[116]  Rosecrans, J.A. Differences in brain area 5-hydroxyrtyptamine 
turnover and rearing behaviour in rats and mice of both sexes. Eur. 
J. Pharmacol., 1970, 9, 379-382.  
[117]  Simon, A.; Volicer, L. Neonatal asphyxia in the rat: greater vulner-
ability of males and persistent effects on brain monoamine synthe-
sis. J. Neurochem., 1976, 26, 893-900. 
[118]  Mendelson, S.D.; McEwen, B.S. Autoradiogrphic analysis of the 
effects of restraint-induced stress on 5-HT-1A, 5-HT-1C and 5-
HT2 receptors in the dorsal hippocampus of male and female rats. 
Neuroendocrinology, 1991, 54, 454-461. 
[119]  Zhang, L.; Ma, W.; Barker, J.L.; Rubinow, D.R. Sex differences in 
expression of serotonin receptors (subtypes 1A and 2A) in rat 
brain: a possible role of testosterone. Neuroscience, 1999, 94, 251-
259. 
[120]  Shors, T.J.; Chua, C.; Falduto, J. Sex differences and opposite 
effects of stress on dendritic spine density in the male versus fe-
male hippocampus. J. Neurosci., 2001, 21, 6292-6297. 
[121]  Juraska, J.M. Sex differences in ‘cognitive regions’ of the rat brain. 
Psychoneuroendocrinology, 1991, 16, 105-109. 
[122]  Stamatakis, A.; Mantelas, A.; Papaioannou, A.; Pondiki, S.; 
Fameli, M.; Stylianopoulou, F. Effects of neonatal handling on   
serotonin-1A subtype receptors in the rat hippocampus. Neuroscience, 
2006, 140, 1-11. 
[123]   Schiller, L.; Jahkel, M.; Oehler, J. The influence of sex and social 
isolation housing on pre and postsynaptic 5-HT-1A receptors. 
Brain Res., 2006, 1103, 76-87. Sex Differences: Raphe-Hippocampal Serotonin  Current Neuropharmacology, 2011, Vol. 9, No. 3    521 
[124]  Bellido, I.; Gomez-Luque, A.; Garcia-Carrera, P.; Rius, F.; de la 
Cuesta, F.S. Female rats show an increased sensibility to the forced 
swim test depressive-like stimulus in the hippocampus and frontal 
cortex 5-HT1A receptors. Neurosci. Lett., 2003, 350, 145-148.  
[125]  Goel, N.; Bale, T.L. Examining the intersection of sex and stress in 
modeling neuropsychiatric disorders. J. Neuroendocrinol.,  2009, 
21, 415-420. 
[126]  Haleem, D.J. Repeated corticosterone treatment attenuates behav-
ioral and neuroendocrine responses to 8-hydroxy-2-di-n-
propylamino tetralin in rats. Life Sci., 1992, 51, 225-230.  
[127]  Gogos, A.; Nathan, P.J.; Guille, V.; Croft, R.J.; van den Buuse, M. 
Estrogen prevents 5-HT1A receptor-induced disruptions of pre-
pulse inhibition in healthy women. Neuropsychopharmacology, 
2006, 31, 885-889. 
[128]   Clarke, W.P.; Saul, M.S. Estrogen effects on 5-HT1A receptors in 
hippocampal membranes from ovariectomized rats: functional and 
binding studies. Brain Res., 1990, 518, 287-291. 
[129]   Piotrowska, A.; Mtynie, K.; Siwek, A.; Dybata, M.; Opoka, W.; 
Poleszak, E.; Nowak, G. Antidepressant like effects of chromium 
chloride in the mouse forced swim test: involvement of glutamater-
gic and serotonergic receptors. Pharmacol. Rep.,  2008,  60, 991-
995. 
[130]  David, S.P.; Murthy, N.V.; Rabiner, E.A.; Munafo, M.R.; 
Johnstone, E.C.; Jacob, R.; Walton, R.T.; Grasby, P.M. A func-
tional genetic variation of the serotonin (5-HT) transporter affects 
5-HT1A receptor binding in humans. J. Neurosci., 2005, 25, 2586-
2590. 
[131]  Parsey, R.V.; Oquenda, M.A.; Ogden, R.T.; Olvet, D.M.; Simpson, 
N.; Huang, Y.Y.; Van Heertum, R.; Arango, V.; Mann, J.J. Altered 
serotonin-1A binding in major depression: a [carbonyl-C-11] 
WAY100635 positron emission tomography study. Biol. Psychia-
try, 2006, 59, 106-113. 
[132]  Palego, L.; Marazzi, D.; Rossi, A.; Giannaccini, G.; Naccarato, 
A.G.; Lucacchini, A.; Cassano, G.B. Apparent absence of aging 
and gender effects on serotonin-1A receptors in human neocortex 
and hippocampus. Brain Res., 1997, 758, 26-32. 
[133]  Parsey, R. V.; Oquenda, M. A.; Simpson, N. R.; Ogden, R. T.; Van 
Heertum, R.; Arango, V.; Mann, J. J. Effects of sex age and aggres-
sive traits in man on brain 5-HT-1A receptor binding potential 
measured by PET using [C-11]WAY-100635. Brain Res.,  2002, 
945, 173-182. 
[134]  Biver, F.; Lotstra, F.; Monclus, M.; Wikler, D.; Damhaut, P.; 
Mendlewicz, J.; Goldman S. Sex difference in 5-HT-2 receptor in 
the living human brain. Neurosci. Lett., 1996, 204, 25-28. 
[135]  Staley, J.K.; Krishnan-Sarin, S.; Tamagnan, G.; Fujita, M.; Seibyl, 
J.P.; Maciejewski, P.K.; O’Malley, S.; Innis, R.B. Sex differences 
in beta-CIT SPECT measures of dopamine and serotonin trans-
porter availability in healthy smokers and non smokers. Synapse, 
2001, 41, 275-284. 
[136]  Staley, J. K.; Sanacora, G.; Tamagnan, G.; Maciejewski, P. K.; 
Malison, R. T.; Berman, R. M.; Vythilingam, M.; Kugaya, A.; 
Baldwin, R.M.; Seibyl, J.P.; Charney, D.; Innis, R. B. Sex differ-
ences in diencephalon serotonin transporter availability in major 
depression. Biol. Psychiatry, 2006, 59, 40-47. 
[137]    Jovanovic, H.; Lundberg, J., Karlsson, P.; Cerin, A.; Saijo, T.; 
Varrone, A.; Halldin, C.; Nordstrom, A. L. Sex differences in the 
serotonin-1A receptor and serotonin transporter binding in the hu-
man brain measured by PET. Neuroimage, 2008, 39, 1408-1419. 
[138]  Stein, P.; Savli, M.W.; Mitterhauser, M.; Fink, M.; Spindelegger, 
C.; Mien, L-K.; Moser, U.; Dudczak, R.; Kletter, K.; Kasper, S.; 
Lanzenberger, R. The serotonin-1A receptor distribution in healthy 
men and women measured by PET and [carbonyl-11C]  WAY-
100635. Eur. J. Nucl. Med. Mol. Imaging, 2008, 35, 2159-2168. 
[139]  Cowen, P.J.; Power, A.C.; Anderson, I.M. 5-HT-1A receptor 
sensitivity in major depression: A neuroendocrine study with 
buspirone. Br. J. Psychiatry, 1994, 164, 372-379. 
[140]  Lesch, K.P. 5-HT-1A receptor responsitivity in anxiety disorder 
and depression. Prog. Neuropsychopharmacol. Biol. Psychiatry, 
1991, 15, 723-733. 
[141]  Drevets, W.C.; Frank, E.; Price, J.C.; Kupfer, D.J.; Greer, P.J.; 
Mathis, C. Serotonin type-1A receptor imaging in depression. Nucl. 
Med. Biol., 2000, 27, 499-507. 
[142]  Sargent, P.A.; Kjaer, K.H.; Bench, C. J.; Rabiner, A.E.; Messa, C.; 
Meyer, J.; Gunn, R.N.; Grasby, P.M.; Cowen, P. J. Brain serotonin-
1A receptor binding measured by positron emission tomography 
with WAY-100635: effects of depression and antidepressant treat-
ment. Arch. Gen. Psychiatry, 2000, 57, 174-180.  
[143]  Sullivan, G.M.; Ogden, R.T.; Oquendo, M.A.; Kumar, J.S.; 
Simpson, N.; Huang, Y.Y.; Mann, J.J.; Parsey, R.V. Positron emis-
sion tomography quantification of serotonin-1A receptor binding in 
medication-free bipolar depression. Biol. Psychiatry,  2009,  66, 
223-230.  
[144]  Thase, M.E.; Entsuah, R.; Cantillon, M.; Kornstein, S.G. Relative 
antidepressant efficacy of venlafaxine and SSRIs: Sex-Age Interac-
tions. J. Women's Health, 2005, 14, 609-616. 
[145]  Martenyi, F.; Dossenbach, M.; Mraz, K.; Metcalfe, S. Gender dif-
ferences in the efficacy of fluoxetine and maprotiline in depressed 
patients: a double blind trial of antidepressants with serotonergic 
and norepinephrinergic reuptake inhibition profile. Eur. Neuropsy-
chopharmacol., 2001, 11, 227-232. 
[146]  Young, E.A.; Kornstein, S.G.; Marcus, S.M.; Harvey, A.T.;   
Warden, D.; Wisniewski, S.R,; Balasubramani, G.K.; Fava, M; 
Trivedi, M.H.; Rush, A.J. Sex differences in response to citalo-
pram: A STAR*D report. J. Psychiat. Res., 2009, 43, 503-511. 
 
 
Received: January 19, 2010  Revised: May 07, 2010  Accepted: October 29, 2010 
 
 